case study- group 5-sem 4

Upload: ah-boon

Post on 14-Apr-2018

216 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 Case Study- Group 5-Sem 4

    1/36

    MPHA 4305 -SBT V

    Case Study 5

    Group 5

  • 7/30/2019 Case Study- Group 5-Sem 4

    2/36

    Group Members:Lau Li Wenn BPM 1109 1317

    Lee Suo Ying BPM 1109 1311

    Lau Wai Hoong BPM 1109 1146

    Lee Soo Mei BPM 1109 1044

    Lee Yee Ling BPM 1109 1036Lee Ming Keat BPM 1109 1310

  • 7/30/2019 Case Study- Group 5-Sem 4

    3/36

    Case History 1

  • 7/30/2019 Case Study- Group 5-Sem 4

    4/36

    A 44-year-old man who had lost his job because of

    absenteenism, presented to his physician complaining of

    loss of appetite, fatigue, muscle weakness, and emotional

    depression.

    The physician examination revealed a somewhat enlarged

    liver that was firm and nodular, and there was a hint of

    jaundice in the sclerae and a hint of alcohol in his breath.

    The initial laboratory profile included a hematologicalanalysis that showed that he had an anemia with enlarged

    red blood cells (macrolytic). A bone marrow aspirate

    confirmed the suspicion he had a megaloblastic anemia

    because it showed a greater than normal number of redand white blood cell precursors, most of which were larger

    than normal. Further analyses revealed that his serum folic

    acid level was 1.2ng/mL (normal 2.5 to 20), his serum B12

    level was 253 ng/mL (normal 200-900), but his serum iron

    level was normal.

  • 7/30/2019 Case Study- Group 5-Sem 4

    5/36

    Patient Background

    Gender : Male

    Age : 44 years old

    Symptoms: loss of appetite

    fatigue

    muscle weakness Emotional depression

  • 7/30/2019 Case Study- Group 5-Sem 4

    6/36

    Physical examination:

    Enlarged liver (firm & nodular)

    Hint ofjaundice in the sclerae Hint ofalcohol in his breath

  • 7/30/2019 Case Study- Group 5-Sem 4

    7/36

    Initial laboratory profile

    Hematological Analysis:

    Anemia with enlarged RBC ( Macrocytic )

    Bone Marrow Aspirate: no.RBC& WBC precursor >normal

    Size LARGER than normal

  • 7/30/2019 Case Study- Group 5-Sem 4

    8/36

    Serum level of

    Folic acid : 1.2ng/mL ( normal 2.5-20 )

    B12 : 253 ng/ml (normal 200-900) Iron : NORMAL

  • 7/30/2019 Case Study- Group 5-Sem 4

    9/36

    Diagnosis:

    Megablastic Anemia

  • 7/30/2019 Case Study- Group 5-Sem 4

    10/36

    What is megaloblastic anemia?

    Enlargement of the red blood cells, and thus

    they are dysfunctional

    Common causes are, Vitamin B12 and folic

    acid deficiency results from

    Malabsorption

    Dietary deficiency

    Gastric diseases

    Liver diseases

    Medication

    Alcoholism

  • 7/30/2019 Case Study- Group 5-Sem 4

    11/36

    What is the cause of megaloblastic anemia in this

    patient? What is its correlation with alcoholism?

    I. Deficiency of folic acid (which may cause byliver disease or alcoholism)

    Liver disease:

    Cell necrosis, which decreases the livers abilityto metabolize and excrete bilirubin, thusunconjugated bilirubin in the blood lead to

    jaundice.

    Interfere with the production and metabolism ofred blood cells, thus abnormal RBC are produced

    Impairs with the absorption and also diminishhepatic storage of folic acid

  • 7/30/2019 Case Study- Group 5-Sem 4

    12/36

    Alcoholism:

    Interfere with the enterohepatic cycle

    Decrease the absorption of folic acid, becauseusually alcoholism will lead to malnutrition

    and thus to the deficiency of many nutrients.

    Why deficiency of nutrients?

    Poor diet

    Intestinal malabsorptionDecrease hepatic uptake

    Increase body excretion, mainly via urine

  • 7/30/2019 Case Study- Group 5-Sem 4

    13/36

    Alcoholism Liverdisease

    Folic aciddeficiency

    Megaloblasticanemia

    Jaundice

    Failed in the

    production

    of normal

    RBC

  • 7/30/2019 Case Study- Group 5-Sem 4

    14/36

    Case History 2

  • 7/30/2019 Case Study- Group 5-Sem 4

    15/36

    Patient is, a malnourished-appearing woman in

    her second trimester of pregnancy, presents to

    the local health clinic for her regular checkup.She is a multiparous, 22-year-old woman who

    ran away from home when she was 16. She has

    a 7-year history of excessive alcohol intake and

    has been using cocaine frequently for 3 years.She lives with her boyfriend and her 19-month-

    old daughter. During both pregnancies, T.J. lost

    8 to 10 Ib during the first trimester secondary

    to nausea, vomitting, and aneroxia. Her onlycomplaints are dyspnea on exertion,

    palpitations, and diarrhea.

  • 7/30/2019 Case Study- Group 5-Sem 4

    16/36

    Pertinent laboratory values include the following:

    Hct, 25.5% (normal, 40 to 44%); MCV 112m3

    (normal, 76 to 100); MCH, 34 pg (normal, 27 to33);RBC, 1.1 X 106 /mm3(normal, 3.5 to 5.0);

    folate, 30ng/mL (normal, in RBC 140 to 960);

    serum vitamin B12, 250 pg/mL (normal, 200 to

    1,000); reticulocytes, 1% (normal, 0.5 to 1.5);platelets, 75,000/mm3 (normal 130,000 to

    400,000); WBC count, 2,000/mm3 (normal, 3,200

    to 9,800 ) with hypersegmented PMN; LDH, 450

    U/L (normal, 50 to 150); and bilirubin, 1.5 mg/dl.

    Normal, 0.1 to 1).

  • 7/30/2019 Case Study- Group 5-Sem 4

    17/36

    Patient Background

    Name : T.J. Gender: Female

    Age : 22 years old

    Malnourished-appearing

    Stage of pregnancy : 2nd trimester

    Has 19-month-old daughter

    Excessive alcohol intake ( 7 years)

    Cocaine administration (3 years)

  • 7/30/2019 Case Study- Group 5-Sem 4

    18/36

    In both pregnancies:

    lost 8-10 Ib in 1st trimester (Nausea,

    vommitting & anorexia)

    Symptoms:

    Dsypnea on exertion, palpitations &

    diarrhea

    P i l b l

  • 7/30/2019 Case Study- Group 5-Sem 4

    19/36

    Pertinent laboratory value:

    Blood Serum level Normal Range

    Hct 25.5% 40-44% Less

    RBC 1.1 X 106 /mm3 3.5-5.0 /mm3 Less

    Folate 30 ng/mL 140-960 ng/mL Less

    Platelets 75,000 /mm3 130,000-400,000/mm3 Less

    WBC(Hypersegmented

    polymorphonuclear

    leukocytes)

    2,000/mm3

    3,200-9,800 /mm3

    Less

    MCV 112 m3 76-100 m3 Greater

    MCH 34 pg 27-33 pg Greater

    LDH 450 U/L 50-150 U/L Greater

    Vitamin B12 250 pg/mL 200-1000 pg/mL Normal

    Recticulocytes 1% 0.5-1.5% Normal

  • 7/30/2019 Case Study- Group 5-Sem 4

    20/36

    Diagnosis?

  • 7/30/2019 Case Study- Group 5-Sem 4

    21/36

    Question 1:

    T.J is not taking any presciption

    medications. What factors make T.J. at

    risk for folate deficiency???

  • 7/30/2019 Case Study- Group 5-Sem 4

    22/36

    1. Pregnancy

    Increased need for folic acidRequire more folate to meet the needs of her

    developing baby.

    If she dont have sufficient folate intake, she

    may become folate deficient and her unborn

    baby may develop a neural tube defect.

    This happens when unborn baby's nerves and

    spinal cord do not develop properly in the firstmonths of pregnancy.

  • 7/30/2019 Case Study- Group 5-Sem 4

    23/36

    2. Malnutrition

    Poor dietary intake of folic acid

    (does not eat enough foods that contain

    folic acid)

    Diets lacking of fresh fruits andvegetables, or consistently overcook food

    Imbalance and unhealthy diet

  • 7/30/2019 Case Study- Group 5-Sem 4

    24/36

    Inadequate dietary intake of folic acid

    interferes with the absorption of folate.

    Drinking too much alcohol can reduce T.J.

    body's ability to absorb and use folate.

    3. Chronic Alcoholism

  • 7/30/2019 Case Study- Group 5-Sem 4

    25/36

    Question 2

    Which laboratory values support thediagnosis of folate deficiency ? How

    should T. J be treated and monitored?

  • 7/30/2019 Case Study- Group 5-Sem 4

    26/36

    The folate concentration in the RBC is only 30ng/mL, which is much lower than the normal

    range. The Vitamin B12 is at normal range.

    The MCV or MCH has increased in the patients,with folate deficiency, indicates the patient

    diagnosed with megaloplastic anemia. The platelets count are low, and the white blood

    cells count are low with hypersegmentedpolymorphonuclear leukocytes.

    Hypersegmented polymorphonuclear leukocytesare the earliest and most specific signs ofmegaloblastic anemia.

  • 7/30/2019 Case Study- Group 5-Sem 4

    27/36

    Treatment

    Oral folic acid therapy can be given,

    because it is inexpensive and stable.

    15mg daily for 4 months due to themalabsorption states.

  • 7/30/2019 Case Study- Group 5-Sem 4

    28/36

    Monitoring the Condition

    Around 10 days after starting treatment, the

    blood test is taken to check whether the levels

    has started to rise.

    Approximately 8 weeks is required for anotherblood test to confirm the treatment has been

    successful.

    The blood test is taken again after the treatment

    has finished.

    C t d 3

  • 7/30/2019 Case Study- Group 5-Sem 4

    29/36

    Case study 3

    A 65-year-old woman presents to the medical out-patient

    department with a history of fatigue. She has in the last few months

    been undergoing adjuvant cytotoxic chemotherapy for a node-positive resected breast cancer. The patient is pale, but no other

    abnormalities are noted. Her full blood count shows a haemoglobin

    level of 9.8 g/dL with a mean corpuscular volume of 86 fL; other

    haematological indices and serum transferrin are normal. Her faecal

    occult blood is negative. She is started on oral iron sulphate andgiven weekly injections of erythropoietin 40 000 U subcutaneously.

    Three months later, her haemoglobin level has risen to 13.5 g/dL,

    but she presents to the Accident and Emergency Department with

    acute-onset dysphasia and weakness of her right arm. Her supine

    blood pressure is 198/122mmHg. Her neurological deficit resolves

    over 24 hours and her blood pressure settles to 170/96 mmHg. She

    has no evidence of cardiac dyshythmias or of carotid disease on

    ultrasonic duplex angiography, and her serum cholesterol

    concentration was 4.2 mmol/L.

  • 7/30/2019 Case Study- Group 5-Sem 4

    30/36

    Summary Gender: woman

    Age: 65 yrs old

    History: fatigue

    Therapy received before: adjuvant cytotoxic

    chemotherapy : node-positive resected breastcancer.

    Haemoglobin level: 9.8 g/dL with a mean

    corpuscular volume of 86 fL

    other haematological indices and serum transferrin:

    normal

    faecal occult blood: negative

  • 7/30/2019 Case Study- Group 5-Sem 4

    31/36

    Treatment: oral iron sulphate & inject erythropoietin

    40 000U (SC) weekly.

    Haemoglobin level after 3 months: risen to 13.5 g/dL

    Accident & emergency department: due to acute-

    onset dysphasia and weakness of her right arm.

    Supine blood pressure: 198/122mmHg.

    After 24 hours, blood pressure- 170/96 mmHg,

    neurological deficit resolves

    Cardiac dyshythmias / carotid disease in ultrasonicduplex angiography- negative

    Serum cholesterol conc.4.2 mmol/L

  • 7/30/2019 Case Study- Group 5-Sem 4

    32/36

    Question 3

    What led to this patients acute neurological episode? Does she

    require further therapy?

  • 7/30/2019 Case Study- Group 5-Sem 4

    33/36

    Question 3

    The 65-year-old woman is diagnosed for a

    node-positive resected breast cancer. She

    had been undergoing cytotoxic

    chemotherapy in the last few months.

  • 7/30/2019 Case Study- Group 5-Sem 4

    34/36

    1) Filgrastim (granulocyte colony-stimulating

    factor; G-CSF).

    2) Sargramostim (granulocyte-macrophage

    colony-stimulating factor; GM-CSF).

    Both stimulate the production of neutrophils

    and accelerate the recovery of neutrophils

    after cancer chemotherapy.

  • 7/30/2019 Case Study- Group 5-Sem 4

    35/36

    4) Oprelvekin (interleukin-11 [IL-11]) increases

    the number of peripheral platelets. It is usedfor the treatment of thrombocytopenia

    patients after had cancer chemotherapy.

    5) It reduces the need for platelettransfusions.

    Common adverse effects of IL-11 are

    fatigue, headache, dizziness, and fluidretention.

  • 7/30/2019 Case Study- Group 5-Sem 4

    36/36

    Serum cholesterol concentration= 4.2mmol/L.

    Total Cholesterol [mmol/L (mg/dl)]

    a) Risk indicated if greater than 4.5

    b) Desirable: =240)

    The first steps in treating high cholesterol

    levels are regular physical activity andhealthy eating.